23 Facts About Ruth Arnon

Ruth Arnon is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone.

Ruth Arnon is currently the Paul Ehrlich Professor of Immunology at the Weizmann Institute of Science, where she is researching anti-cancer and influenza vaccinations.

Ruth Arnon attended Herzliya Hebrew Gymnasium and knew she wanted to be a medical researcher by the age of 15.

Ruth Arnon studied chemistry at the Hebrew University of Jerusalem before joining the Israel Defense Forces's Atuda academic study program.

Ruth Arnon has focused most of her life on the field of immunology.

Much of Ruth Arnon's work has been in the development of vaccinations and cancer research.

Ruth Arnon served as the Chairperson of the Sciences division of the Israel Academy of Sciences from 1995 to 2001.

Ruth Arnon later was elected as President of the Israel Academy.

Ruth Arnon is a member of the EMBO, the European Molecular Biology Organization.

Ruth Arnon served as Secretary-General of the International Union of Immunological Sciences, the President of the European Federation of Immunological Societies, and is a member of the European Union Research Advisory Board.

Ruth Arnon has published more than four hundred articles in biochemistry and immunology.

Ruth Arnon was a visiting professor at the Rockefeller Institute, University of Washington, University of California, Pasteur Institute, Walter and Elise Hall Institute, Imperial Cancer Research Fund, and the Curie Institute.

Since multiple sclerosis is an immunological disease, Cop 1 is an immunospecific drug, which is no surprise, as Ruth Arnon has focused the majority of her work in the field of immunology.

Ruth Arnon is researching a universal, recombinant influenza vaccination, as well as a cancer vaccine.

In 2017 Ruth Arnon was appointed co-chair of the UK-Israel Science Council, alongside Prof.

Ruth Arnon has been a founding member of the council since 2010.

Summary Ruth Rosenberg was the youngest of three children born in Tel Aviv.

Ruth Arnon went to work for the Israel Electric Corporation after they returned to Israel.

Ruth Arnon's father, according to Arnon, sparked her interest in science.

Ruth Arnon's work has mostly focused on the creation of vaccines and cancer studies.

Ruth Arnon has spent the majority of her career working in the field of immunology.

Currently, Ruth Arnon is working on a recombinant influenza vaccine that is universal as well as a cancer vaccine.

Ruth Arnon has won 12 awards and recognitions in her career.